Mechanisms of immune red cell destruction, and red cell compatibility testing.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6601047)

Published in Hum Pathol on March 01, 1983

Authors

G Garratty

Articles by these authors

(truncated to the top 100)

Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion (1999) 2.66

Misinterpretation and misapplication of p values in antibody identification: the lack of value of a p value. Transfusion (1997) 2.36

First year donation patterns predict long-term commitment for first-time donors. Vox Sang (2005) 2.18

More on p values in antibody identification. Transfusion (1998) 1.89

Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion (2000) 1.61

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51

Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion (1997) 1.51

An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transfusion (1985) 1.38

First-time blood donors: demographic trends. Transfusion (2001) 1.23

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang (2011) 1.19

Drug-induced immune hemolytic anemia. Am J Med (1975) 1.17

International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang (2009) 1.17

International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang (2003) 1.16

Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang (2004) 1.11

Autoantibodies in acquired hemolytic anemia with special reference to the LW system. Blood (1973) 1.00

Transfusing patients with autoimmune haemolytic anaemia. Lancet (1993) 0.96

Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology (2009) 0.95

The correlation of cold agglutinin titrations in saline and albumin with haemolytic anaemia. Br J Haematol (1977) 0.95

Clinical significance of anti-At(a). Vox Sang (1995) 0.95

Tn polyagglutination preceding acute leukemia. Blood (1979) 0.93

Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood (1984) 0.92

Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method. Am J Clin Pathol (1989) 0.90

International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang (2007) 0.90

The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera. Transfusion (1976) 0.89

Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors. Transfus Med (2005) 0.89

The effects of storage and heparin on the activity of serum complement, with particular reference to the detection of blood group antibodies. Am J Clin Pathol (1970) 0.89

Erythrophagocytosis on the peripheral blood smear and paroxysmal cold hemoglobinuria. Transfusion (2001) 0.88

Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion (1987) 0.88

Acquired loss of red cell Kell antigens. Br J Haematol (1987) 0.87

Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia. Blood (1974) 0.86

In vitro studies of the impact of transfusion on the detection of alloantibodies after autoadsorption. Transfusion (2000) 0.86

Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells. Transfus Med (2004) 0.86

Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol (1971) 0.86

Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method. Vox Sang (2002) 0.85

Application of flow cytometry to immunohematology. J Immunol Methods (1987) 0.85

What do we mean by "Hyperhaemolysis" and what is the cause? Transfus Med (2012) 0.84

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012). Vox Sang (2013) 0.84

Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion (1992) 0.84

The role of compatibility tests. (Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee). Transfusion (1982) 0.83

A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med (1999) 0.83

An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C. Transfusion (1998) 0.83

Autoimmune hemolytic anemia after Kawasaki disease in a child. Int J Hematol (1993) 0.82

An evaluation of commercial antiglobulin sera with particular reference to their anticomplement properties. Transfusion (1971) 0.82

Effect of storage on antibody reactivity after adsorption in the presence of polyethylene glycol. Transfusion (2000) 0.82

Complement in immunohematology. Prog Clin Immunol (1974) 0.82

Congenital dyserythropoietic anemia (CDA) with increased red cell lipids. Am J Med (1974) 0.81

Autoimmune hemolytic anemia associated exclusively with IgA of Rh specificity. Transfusion (1979) 0.81

Reappraisal of the role of anti-i in haemolytic anaemia in infectious mononucleosis. Br J Haematol (1973) 0.81

Studies on the immune response to penicillin and cephalothin in humans. I. Optimal conditions for titration of hemagglutinating penicillin and cephalothin antibodies. J Immunol (1971) 0.80

A clinically significant erythrocyte antibody detectable only by 51Cr survival studies. Transfusion (1983) 0.80

Acute immune intravascular hemolysis due to hydrochlorothiazide. Am J Clin Pathol (1981) 0.79

Immunologic reactions in penicillin factory workers. Ann Allergy (1976) 0.79

Terminology for red cell surface antigens. ISBT Working Party Oslo Report. International Society of Blood Transfusion. Vox Sang (1999) 0.79

Paroxysmal cold hemoglobinuria: report of a case with an exceptionally high thermal range Donath-Landsteiner antibody. Blood (1971) 0.79

Antiglobulin sera--past, present and future. Transfusion (1978) 0.79

International Society of Blood Transfusion Working Party on Terminology for Red Cell Surface Antigens. Vox Sang (2001) 0.78

A second case of post-transfusion purpura caused by HPA-5a antibodies: successful treatment with intravenous immunoglobulin. Vox Sang (2002) 0.78

Standardization of IgG subclass antiserums for use with sensitized red cells. Transfusion (1983) 0.78

A new potentiator of red blood cell antigen-antibody reactions. Am J Clin Pathol (1987) 0.78

Evaluation of the Amicus Separator in the collection of apheresis platelets. Transfusion (1998) 0.78

Autoimmune hemolytic anemia associated with IgG auto anti-N. Transfusion (1979) 0.77

Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr (1998) 0.77

An IgA high-titer cold agglutinin with an unusual blood group specificity within the Pr complex. Vox Sang (1973) 0.76

Immune hemolytic anemia associated with probenecid. Am J Clin Pathol (1985) 0.76

Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto-anti-Jka. Transfusion (1984) 0.76

Evaluation of the optimal incubation temperature for detecting certain IgG antibodies with potential clinical significance. Transfusion (1988) 0.76

Erythrocyte-bound complement components in health and disease. Prog Clin Biol Res (1980) 0.76

Red cell-bound complement associated with ABO-hemolytic disease of the newborn. Vox Sang (1992) 0.75

Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole. Transfus Med (2010) 0.75

Rapid enzymatic analysis for human immunodeficiency virus type 1 DNA in clinical specimens. Clin Chem (1993) 0.75

Clinical significance of the anti-complement component of antiglobulin antisera. Transfusion (1982) 0.75

A tribute to Georg Springer, MA, MD, DSc (Hon)--who laid a foundation for using the relationship of blood groups to disease as a basis for the diagnosis and treatment of patients. Transfus Med Rev (2000) 0.75

Statistics in articles published in TRANSFUSION. Transfusion (1994) 0.75

Attack on prewarmed tests--too much hot air? Transfusion (1996) 0.75

Auto-anti-A associated with immune hemolytic anemia. Vox Sang (1992) 0.75

Linear vs. logarithmic settings in flow cytometric analyses. Transfus Med (2000) 0.75

Preparation of reticulocyte-rich red cells using LeucoPREP. Transfusion (1989) 0.75

Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism. Transfusion (1990) 0.75

Immune hemolytic anemia associated with anti-Kell and a carrier state for chronic granulomatous disease. Rev Fr Transfus Immunohematol (1979) 0.75

Elution of antibody from red blood cells using xylene--a superior method. Transfusion (1981) 0.75

Clinical significance of an anti-Dib assessed by flow cytometry. Immunohematology (1997) 0.75

Drug-induced immune cytopenia. Transfus Med Rev (1993) 0.75

False-positive eluate reactivity due to the low-ionic wash solution used with commercial acid-elution kits. Transfusion (1998) 0.75

Flow cytometry: its applications to immunohaematology. Baillieres Clin Haematol (1990) 0.75

Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol (1989) 0.75

Ethics and the journal Transfusion. Transfusion (1989) 0.75

Correlation of IgG subclass with the severity of hemolytic disease of the newborn. Transfusion (1990) 0.75

Isoimmunization to Cromer antigen in pregnancy. Am J Obstet Gynecol (1989) 0.75

Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion (1993) 0.75

A new form of polyagglutination related to Cad. Immunohematology (1996) 0.75

Warm autoimmune hemolytic anemia associated with an IgM autoanti-Ge. Immunohematology (1998) 0.75

Immune hemolytic anemia associated with mefloquine. Transfusion (1998) 0.75

Review: Immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology (1994) 0.75

Cell surface heterogeneity of human blood neutrophils and monocytes. Br J Haematol (1979) 0.75

Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn. Am J Perinatol (1993) 0.75

M and N specific hemagglutinins of human erythrocytes stored in glucose solutions. Transfusion (1982) 0.75

Studies on hemolytic anemia in pregnancy with evidence for autoimmunization in a patient with a negative direct antiglobulin (Coombs') test. Am J Hematol (1980) 0.75

Investigations of the potential for five beta-lactam antibiotics to elicit type II hypersensitivity reactions in rats and monkeys. Fundam Appl Toxicol (1989) 0.75

A simple method for inhibiting ABO antibodies in sera used for platelet crossmatching. Immunohematology (1990) 0.75